Literature DB >> 7769669

Dissociation of the CD4 downregulation and viral infectivity enhancement functions of human immunodeficiency virus type 1 Nef.

M A Goldsmith1, M T Warmerdam, R E Atchison, M D Miller, W C Greene.   

Abstract

Recent evidence indicates that the nef gene of human immunodeficiency virus type 1 augments rather than inhibits viral replication in both cell culture and in vivo models. In addition, nef alters various normal cellular processes, including the display of CD4 on the cell surface. However, it remains unknown whether the enhancement of infectivity and the downregulation of CD4 represent linked or independent biologic properties of this single protein. In the present studies, mutational analyses were performed to define structure-function relationships within the Nef protein that mediate these effects. To assess the functional consequences of these mutations, sensitive and reliable assays were developed to quantitate the viral infectivity enhancement and CD4 downregulation functions of Nef. The results indicate that membrane-targeting sequences at the N terminus of Nef are important for both functions of Nef, while certain other conserved regions are dispensable for both functions. A conserved proline-X-X repeat segment in the central core of the protein, which is reminiscent of an SH3-binding domain, is critical for the enhancement of infectivity function but is dispensable for CD4 downregulation. However, the downregulation of CD4 by Nef appears to involve a two-step process requiring the initial dissociation of p56lck from CD4 to permit engagement of the endocytic apparatus by CD4. Together, these findings demonstrate that the infectivity enhancement and CD4 downregulation activities of human immunodeficiency virus type 1 Nef can be dissociated. Thus, these processes may be independent of one another in the viral replication cycle.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769669      PMCID: PMC189146          DOI: 10.1128/JVI.69.7.4112-4121.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Identification of a ten-amino acid proline-rich SH3 binding site.

Authors:  R Ren; B J Mayer; P Cicchetti; D Baltimore
Journal:  Science       Date:  1993-02-19       Impact factor: 47.728

2.  Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function.

Authors:  E Zazopoulos; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

3.  Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo.

Authors:  D C Shugars; M S Smith; D H Glueck; P V Nantermet; F Seillier-Moiseiwitsch; R Swanstrom
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells.

Authors:  S Anderson; D C Shugars; R Swanstrom; J V Garcia
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  The negative effect of human immunodeficiency virus type 1 Nef on cell surface CD4 expression is not species specific and requires the cytoplasmic domain of CD4.

Authors:  J V Garcia; J Alfano; A D Miller
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

6.  Members of the src family of nonreceptor tyrosine kinases share a common mechanism for membrane binding.

Authors:  L Silverman; M Sudol; M D Resh
Journal:  Cell Growth Differ       Date:  1993-06

7.  CD4 down-regulation by nef alleles isolated from human immunodeficiency virus type 1-infected individuals.

Authors:  R Mariani; J Skowronski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

8.  Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene.

Authors:  J Skowronski; D Parks; R Mariani
Journal:  EMBO J       Date:  1993-02       Impact factor: 11.598

9.  Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src.

Authors:  L Silverman; M D Resh
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

10.  Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection.

Authors:  R E Benson; A Sanfridson; J S Ottinger; C Doyle; B R Cullen
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  81 in total

1.  Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions.

Authors:  L X Liu; N Heveker; O T Fackler; S Arold; S Le Gall; K Janvier; B M Peterlin; C Dumas; O Schwartz; S Benichou; R Benarous
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.

Authors:  E Schaeffer; R Geleziunas; W C Greene
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix.

Authors:  Tatyana Dorfman; Elena Popova; Massimo Pizzato; Heinrich G Göttlinger
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

5.  Neutron reflectometry study of the conformation of HIV Nef bound to lipid membranes.

Authors:  Michael S Kent; Jaclyn K Murton; Darryl Y Sasaki; Sushil Satija; Bulent Akgun; Hirsh Nanda; Joseph E Curtis; Jaroslaw Majewski; Christopher R Morgan; John R Engen
Journal:  Biophys J       Date:  2010-09-22       Impact factor: 4.033

6.  Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease.

Authors:  B Schramm; M L Penn; R F Speck; S Y Chan; E De Clercq; D Schols; R I Connor; M A Goldsmith
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.

Authors:  Y Kawano; Y Tanaka; N Misawa; R Tanaka; J I Kira; T Kimura; M Fukushi; K Sano; T Goto; M Nakai; T Kobayashi; N Yamamoto; Y Koyanagi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo.

Authors:  Mamoru Matsubara; Tao Jing; Kumi Kawamura; Naoshi Shimojo; Koiti Titani; Keiichiro Hashimoto; Nobuhiro Hayashi
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

9.  Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells.

Authors:  Minoru Tobiume; Janet E Lineberger; Christopher A Lundquist; Michael D Miller; Christopher Aiken
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection.

Authors:  R F Speck; M L Penn; J Wimmer; U Esser; B F Hague; T J Kindt; R E Atchison; M A Goldsmith
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.